News
FDA grants priority review to drug for PNH
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has accepted for priority review the biologics license application (BLA) for ALXN1210, a long-acting C5...
News
Role of SES in childhood cancer survival disparities
- Author:
- HT Staff
Socioeconomic status (SES) may explain some racial/ethnic disparities in childhood cancer survival, according to new research. The study showed...
News
Marzeptacog alfa may prevent bleeds in hemophilia A/B with inhibitors
- Author:
- HT Staff
BOSTON—The activated factor VIIa variant marzeptacog alfa has demonstrated efficacy as prophylaxis for patients with hemophilia A or B who also...
News
Inhibitor receives orphan designation for AML
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has granted orphan drug designation to ASLAN003 as a treatment for acute myeloid leukemia (AML)....
News
Access to care drives disparity between urban, rural cancer patients
- Author:
- HT Staff
New research suggests that better access to quality care may reduce disparities in survival between cancer patients living in rural areas of the...
News
Partial hold placed on trial of drug for AML, MDS
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has placed a partial clinical hold on a phase 1b/2 study of OXi4503, a vascular disrupting agent. In...
News
Some PE patients don’t require hospitalization
- Author:
- HT Staff
A new study suggests that certain patients with acute pulmonary embolism (PE) may be better off receiving outpatient treatment. Researchers...
News
CPI-613 receives orphan designation for PTCL
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has granted orphan drug designation to CPI-613 for the treatment of peripheral T-cell lymphoma (PTCL)....
News
FDA approves assay to screen blood for Zika
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has approved the Procleix® Zika Virus Assay for blood screening. The assay is approved to detect Zika...
News
Team reports ‘simple’ way for GPs to rule out MM
- Author:
- HT Staff
Researchers say they have determined which blood tests can help general practitioners (GPs) rule out a diagnosis of multiple myeloma (MM). The...
News
Study links communication, outcomes in cancer
- Author:
- HT Staff
Better communication between cancer patients and healthcare providers may provide tangible benefits, according to research published in JNCCN....
News
Drug under priority review for BPDCN
- Author:
- HT Staff
The US Food and Drug Administration(FDA) has accepted for priority review the biologics license application seeking approval for tagraxofusp (...
News
Mogamulizumab prolongs PFS in CTCL
- Author:
- HT Staff
Mogamulizumab is an effective treatment option for relapsed/refractory cutaneous T-cell lymphoma (CTCL), according to researchers. In the phase 3...
News
Familial risk of myeloid malignancies
- Author:
- HT Staff
A large study has revealed “the strongest evidence yet” supporting genetic susceptibility to myeloid malignancies, according to a researcher. The...
News
Ixazomib could improve treatment of AML
- Author:
- HT Staff
New research suggests the FOXM1 protein plays an important role in acute myeloid leukemia (AML) progression, and targeting FOXM1 could improve AML...